Please use this identifier to cite or link to this item:
|Title:||Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine.|
|Authors:||Ching, M S;Blake, C L;Malek, N A;Angus, Peter W;Ghabrial, Hany|
Department of Medicine, University of Melbourne, Austin & Repatriation Medical Centre, Victoria, Australia
|Citation:||Xenobiotica; the Fate of Foreign Compounds in Biological Systems; 31(11): 757-67|
|Abstract:||1. The inhibition of recombinant CYP1A1 and CYP1A2 activity by quinidine and quinine was evluated using ethoxyresorutin O-deethylation, phenacetin O-deethylation and propranolol desisopropylation as probe catalytic pathways. 2. With substrate concentrations near the Km of catalysis, both quinidine and quinine potently inhibited CYP1A1 activity with [I](0.5) approximately 1-3 microM, whereas in contrast, there was little inhibition of CYP1A2 activity. The Lineweaver-Burk plots with varying inhibitor concentrations suggested that inhibition by quinidine and quinine was competitive. 3. There was only trace metabolism of quinidine by recombinant CYP1A1, whereas rat liver microsomes as a control showed extensive consumption of quinidine and metabolite production. 4. This work suggests that quinidine is a non-classical inhibitor of CYP1A1 and that it is not as highly specific at inhibiting CYP2D6 as previously thought.|
|Internal ID Number:||11765139|
Cytochrome P-450 CYP1A1.antagonists & inhibitors.genetics.metabolism
Cytochrome P-450 CYP1A2.genetics.metabolism
Cytochrome P-450 CYP1A2 Inhibitors
Microsomes, Liver.drug effects.metabolism
Recombinant Proteins.antagonists & inhibitors.genetics.metabolism
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.